ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PRME Prime Medicine Inc

5.56
0.64 (13.01%)
May 01 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 815,155
Bid Price 5.19
Ask Price 5.55
News (1)
Day High 5.59

Low
4.11

52 Week Range

High
17.20

Day Low 4.85
Share Name Share Symbol Market Stock Type
Prime Medicine Inc PRME NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.64 13.01% 5.56 19:00:00
Open Price Low Price High Price Close Price Previous Close
4.88 4.85 5.59 5.27 4.92
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
8,882 815,155 US$ 5.22 US$ 4,257,215 - 4.11 - 17.20
Last Trade Type Quantity Price Currency
18:29:53 50 US$ 5.45 USD

Prime Medicine Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
630.88M 119.94M - 0 -198.13M -1.65 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Prime Medicine News

Date Time Source News Article
5/01/202407:00GlobeNewswire Inc.Prime Medicine to Participate in the 27th Annual Milken..
4/29/202406:00GlobeNewswire Inc.Prime Medicine Announces FDA Clearance of Investigational..
4/23/202407:00GlobeNewswire Inc.Prime Medicine to Present Preclinical Data Demonstrating..
3/01/202407:09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
3/01/202407:04Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/01/202407:01Edgar (US Regulatory)Form 8-K - Current report
3/01/202407:00GlobeNewswire Inc.Prime Medicine Reports Full Year 2023 Financial Results and..
2/28/202407:00GlobeNewswire Inc.Prime Medicine to Participate in Upcoming Investor..
2/23/202416:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/23/202416:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/22/202420:31Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial..
2/20/202416:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PRME Message Board. Create One! See More Posts on PRME Message Board See More Message Board Posts

Historical PRME Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.795.594.114.69896,4470.7716.08%
1 Month6.386.454.115.17814,979-0.82-12.85%
3 Months6.809.774.116.75759,777-1.24-18.24%
6 Months6.509.864.117.17653,586-0.94-14.46%
1 Year13.7717.204.119.17529,690-8.21-59.62%
3 Years18.9721.73014.1110.58431,079-13.41-70.69%
5 Years18.9721.73014.1110.58431,079-13.41-70.69%

Prime Medicine Description

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs.

Your Recent History

Delayed Upgrade Clock